JP2012509931A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509931A5 JP2012509931A5 JP2011538083A JP2011538083A JP2012509931A5 JP 2012509931 A5 JP2012509931 A5 JP 2012509931A5 JP 2011538083 A JP2011538083 A JP 2011538083A JP 2011538083 A JP2011538083 A JP 2011538083A JP 2012509931 A5 JP2012509931 A5 JP 2012509931A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- methyl
- anhydro
- dideoxy
- diazabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1CCCC1 Chemical compound *C1CCCC1 0.000 description 6
- UKRIBWFNQJMELT-WAYWQWQTSA-N C/N=C1\COCC1 Chemical compound C/N=C1\COCC1 UKRIBWFNQJMELT-WAYWQWQTSA-N 0.000 description 1
- IKFKTKLTADWXNX-UHFFFAOYSA-N CN(C)C1CCOCC1 Chemical compound CN(C)C1CCOCC1 IKFKTKLTADWXNX-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11805308P | 2008-11-26 | 2008-11-26 | |
| US61/118,053 | 2008-11-26 | ||
| PCT/IB2009/055232 WO2010061329A1 (en) | 2008-11-26 | 2009-11-20 | 3-aminocyclopentanecarboxamides as chemokine receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012509931A JP2012509931A (ja) | 2012-04-26 |
| JP2012509931A5 true JP2012509931A5 (enExample) | 2012-08-09 |
| JP5108153B2 JP5108153B2 (ja) | 2012-12-26 |
Family
ID=41693100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011538083A Active JP5108153B2 (ja) | 2008-11-26 | 2009-11-20 | ケモカイン受容体モジュレーターとしての３−アミノシクロペンタンカルボキサミド |
Country Status (38)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2370442B9 (en) * | 2008-11-26 | 2013-09-04 | Pfizer Inc. | 3-Aminocyclopentanecarboxamides as chemokine receptor modulators |
| KR101303963B1 (ko) * | 2011-04-08 | 2013-09-05 | 재단법인 경기과학기술진흥원 | (1ｒ,2ｒ,3ｒ)-3-아미노사이클로펜탄-1,2-디올을 포함하는 항알러지용 조성물 |
| AU2015240465B2 (en) | 2014-04-04 | 2020-02-27 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| TW201605451A (zh) * | 2014-07-17 | 2016-02-16 | 參天製藥股份有限公司 | 老年性黃斑部病變之預防或治療劑 |
| JOP20190040A1 (ar) * | 2016-09-14 | 2019-03-10 | Novartis Ag | توليفة من ناهضات fxr |
| TWI830733B (zh) * | 2018-05-11 | 2024-02-01 | 中國大陸商迪哲（江蘇）醫藥有限公司 | 環戊烷化合物 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU693143B2 (en) | 1993-12-06 | 1998-06-25 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| AU2964295A (en) | 1994-07-11 | 1996-02-09 | Athena Neurosciences, Inc. | Inhibitors of leukocyte adhesion |
| US5462208A (en) | 1994-08-01 | 1995-10-31 | The Procter & Gamble Company | Two-phase dispensing systems utilizing bellows pumps |
| US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| GB9524630D0 (en) | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| WO1996031206A2 (en) | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
| US5704960A (en) | 1995-12-20 | 1998-01-06 | Corning, Inc. | Method of forming an optical fiber for reduced polarization effects in amplifiers |
| GB9603741D0 (en) | 1996-02-22 | 1996-04-24 | Lin Mei | Treatment of water by electrolysis |
| JP2000516210A (ja) | 1996-07-12 | 2000-12-05 | ロイコサイト，インコーポレーテッド | ケモカインレセプターアンタゴニストとその使用方法 |
| WO1998042656A1 (en) | 1997-03-21 | 1998-10-01 | Cytel Corporation | Novel compounds |
| ES2257808T3 (es) | 1997-05-29 | 2006-08-01 | MERCK & CO., INC. (A NEW JERSEY CORP.) | Acidos biarilalcanoicos como inhibidores de adhesion celular. |
| AU728435B2 (en) | 1997-05-29 | 2001-01-11 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
| CA2291778A1 (en) | 1997-05-29 | 1998-12-03 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| ATE256699T1 (de) | 1997-05-30 | 2004-01-15 | Celltech Therapeutics Ltd | Entzündungshemmende tyrosin-derivate |
| PT991619E (pt) | 1997-06-23 | 2004-02-27 | Upjohn Co | Inibidores da adesao celular mediada pela alfa4beta1 |
| US6312689B1 (en) | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
| JO2479B1 (en) | 2002-04-29 | 2009-01-20 | ميرك شارب اند دوم ليمتد | Rates for the activity of the chemokine receptor of tetrahydrobranyl cycloneptil tetrahydrobredo predine |
| DK1501507T3 (da) * | 2002-04-29 | 2008-09-29 | Merck & Co Inc | Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet |
| GEP20084505B (en) | 2003-12-18 | 2008-10-10 | Incyte Corp | 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| AU2005219438B2 (en) * | 2004-03-03 | 2011-02-17 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| JP2007534755A (ja) | 2004-04-28 | 2007-11-29 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性のモジュレーターとなる３，３−ジ置換テトラヒドロピラニルシクロペンチルアミド |
| EP1763347A4 (en) * | 2004-06-28 | 2009-05-20 | Incyte Corp | 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS |
| CN1976707A (zh) * | 2004-06-28 | 2007-06-06 | 因赛特公司 | 作为趋化因子受体调节剂的3－氨基环戊烷甲酰胺类 |
| AP2006003849A0 (en) | 2004-06-28 | 2006-12-31 | Incyte Corp | 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors |
| MEP1008A (xx) | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
| EP2370442B9 (en) * | 2008-11-26 | 2013-09-04 | Pfizer Inc. | 3-Aminocyclopentanecarboxamides as chemokine receptor modulators |
-
2009
- 2009-11-20 EP EP09774939.4A patent/EP2370442B9/en active Active
- 2009-11-20 BR BRPI0920936-0A patent/BRPI0920936A2/pt not_active Application Discontinuation
- 2009-11-20 PT PT97749394T patent/PT2370442E/pt unknown
- 2009-11-20 ES ES09774939T patent/ES2415430T3/es active Active
- 2009-11-20 PL PL09774939T patent/PL2370442T3/pl unknown
- 2009-11-20 UA UAA201106571A patent/UA99978C2/uk unknown
- 2009-11-20 GE GEAP200912239A patent/GEP20146064B/en unknown
- 2009-11-20 HR HRP20130409AT patent/HRP20130409T2/hr unknown
- 2009-11-20 CN CN200980147183.7A patent/CN102227429B/zh not_active Expired - Fee Related
- 2009-11-20 EA EA201170721A patent/EA020470B1/ru not_active IP Right Cessation
- 2009-11-20 MX MX2011005526A patent/MX2011005526A/es active IP Right Grant
- 2009-11-20 DK DK09774939.4T patent/DK2370442T5/da active
- 2009-11-20 RS RS20130260A patent/RS52810B9/sr unknown
- 2009-11-20 MY MYPI20112377 patent/MY152557A/en unknown
- 2009-11-20 PE PE2011001105A patent/PE20110831A1/es active IP Right Grant
- 2009-11-20 ME MEP-2011-83A patent/ME01144B/me unknown
- 2009-11-20 AU AU2009321221A patent/AU2009321221B2/en not_active Ceased
- 2009-11-20 NZ NZ592919A patent/NZ592919A/xx not_active IP Right Cessation
- 2009-11-20 CA CA2743030A patent/CA2743030C/en not_active Expired - Fee Related
- 2009-11-20 SI SI200930601T patent/SI2370442T1/sl unknown
- 2009-11-20 JP JP2011538083A patent/JP5108153B2/ja active Active
- 2009-11-20 AP AP2011005732A patent/AP3113A/xx active
- 2009-11-20 RS RS20130260D patent/RS52810B8/sr unknown
- 2009-11-20 KR KR1020117011887A patent/KR101374412B1/ko not_active Expired - Fee Related
- 2009-11-20 WO PCT/IB2009/055232 patent/WO2010061329A1/en not_active Ceased
-
2010
- 2010-06-07 US US12/795,266 patent/US8293903B2/en active Active
-
2011
- 2011-05-05 IL IL212732A patent/IL212732A/en active IP Right Grant
- 2011-05-18 TN TN2011000254A patent/TN2011000254A1/fr unknown
- 2011-05-24 NI NI201100102A patent/NI201100102A/es unknown
- 2011-05-24 CO CO11064157A patent/CO6361921A2/es active IP Right Grant
- 2011-05-25 DO DO2011000154A patent/DOP2011000154A/es unknown
- 2011-05-25 EC EC2011011081A patent/ECSP11011081A/es unknown
- 2011-05-25 CL CL2011001223A patent/CL2011001223A1/es unknown
- 2011-05-26 MA MA33895A patent/MA32834B1/fr unknown
- 2011-05-26 SV SV2011003923A patent/SV2011003923A/es unknown
- 2011-05-26 CR CR20110275A patent/CR20110275A/es unknown
- 2011-05-26 CU CU2011000121A patent/CU24022B1/es active IP Right Grant
- 2011-06-01 ZA ZA2011/04069A patent/ZA201104069B/en unknown
-
2012
- 2012-09-14 US US13/616,375 patent/US8946413B2/en active Active
-
2013
- 2013-05-29 CY CY20131100427T patent/CY1114020T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018534326A5 (enExample) | ||
| US11197867B2 (en) | Aminopyrimidinyl compounds | |
| JP2012509931A5 (enExample) | ||
| JP6162144B2 (ja) | ４，４−二置換−１，４−ジヒドロピリミジン、及びｂ型肝炎の処置のための医薬としてのその使用 | |
| JP2016523911A5 (enExample) | ||
| IL273924B1 (en) | Muscarinic acetylcholine M4 receptor antagonists | |
| AU2012299080B2 (en) | Pyrimidine PDE10 inhibitors | |
| HRP20160326T1 (hr) | Derivati piperidin-4-il azetidina kao inhibitori jak1 | |
| HRP20110158T1 (hr) | Biaril eterski spojevi ureje | |
| JP2018538307A5 (enExample) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| JP2013545779A5 (enExample) | ||
| MX2012004753A (es) | Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina. | |
| JP2013533300A (ja) | ブルトン型チロシンキナーゼの阻害剤 | |
| HRP20180384T1 (hr) | Derivati 2,3-dihidro-benzo[1,4]oksazina i odgovarajući spojevi kao inhibitori kinaze fosfoinozitida-3 (pi3k) za liječenje primjerice reumatoidnog artritisa | |
| WO2014147586A1 (en) | 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh | |
| JP2017523215A5 (enExample) | ||
| WO2019034973A1 (en) | PYRAZOLO [1,5-A] PYRAZIN-4-YL AND RELATED DERIVATIVES | |
| HRP20201158T1 (hr) | Derivati indolin-2-ona | |
| JP2019530708A5 (enExample) | ||
| JP2023021277A5 (enExample) | ||
| TW201247657A (en) | Isoxazolines as therapeutic agents | |
| RU2014118966A (ru) | Способ получения изоксазолил-метокси-никотиновых кислот | |
| HRP20130409T2 (hr) | 3-aminociklopentankarboksamidi kao modulatori kemokinskih receptora | |
| JP2016500109A5 (enExample) |